Skip Nav Destination
Search Results for outcome-based pricing
1-20 of 916 Search Results for
J Health Polit Policy Law (2018) 43 (1): 5–18.
Published: 01 February 2018
...Rachel Sachs; Nicholas Bagley; Darius N. Lakdawalla Abstract In recent years, drug manufacturers and private payers have expressed interest in novel pricing models that more closely link a drug's price to its value. Indication-based pricing, outcome-based pricing, drug licenses, and drug mortgages...
J Health Polit Policy Law (2018) 43 (3): 401–425.
Published: 01 June 2018
.... Despite the apparent advantages for linking evidence to policy, the resulting deliberations did not yield simple policy outcomes with regard to whether or not to adjust value-based purchasing programs for social risk. For health services researchers in general, and particularly for those who believe that...
J Health Polit Policy Law (2015) 40 (4): 711–744.
Published: 01 August 2015
... the antigovernment sentiment it reflected, and with broad adoption of a health maintenance organization (HMO) strategy that relied on narrow networks and price concessions from providers, state-based all-payer price regulation was dropped, with only Maryland's rate-setting approach continuing. Prices...
J Health Polit Policy Law (2000) 25 (6): 1051–1081.
Published: 01 December 2000
... which we examined empirically the relationship between market concentration and pricing patterns for three types of nonprofit hospitals that are distinguishable based on degree of community control: an independent hospital, a member of a local hospital system, and a member of a nonlocal hospital system...
J Health Polit Policy Law (1981) 5 (4): 634–650.
Published: 01 August 1981
... number which gives the percentage increase in quantity sold which would accompany a one percent decrease in price. The market outcome under monopoly is that price exceeds marginal costs of production, and an economic profit accrues to the producer. In addition, price multiplied by the additional...
J Health Polit Policy Law (2011) 36 (4): 649–689.
Published: 01 August 2011
... information about the underlying costs of providing a good or service; then it sets the price based on that information. All competitive-bidding systems must have some incentive for suppliers to be not only efficient but also to submit bids that are close to their own costs. For example, in bidding...
J Health Polit Policy Law (2014) 39 (3): 691–705.
Published: 01 June 2014
... suggest that Russia consider adopting value-based pricing, and in the short term, that it introduce direct price negotiations and price drugs according to reference countries that use health technology assessment. Although generic market shares are high, generic medicine prices are higher than they should...
J Health Polit Policy Law (2016) 41 (5): 1033–1045.
Published: 01 October 2016
...Sandra J. Tanenbaum Abstract Value-based purchasing (VBP) is a widely favored strategy for improving the US health care system. The meaning of value that predominates in VBP schemes is (1) conformance to selected process and/or outcome metrics, and sometimes (2) such conformance at the lowest...
J Health Polit Policy Law (1987) 12 (3): 409–426.
Published: 01 June 1987
... are $9500 higher, indicating a substantially more expensive case mix. Combining volume, outcomes related to quality of care, and price. In the sections above, we primarily focused on the situations and implications that might arise if selective contracting were individually based on...
J Health Polit Policy Law (1982) 7 (3): 746–748.
Published: 01 June 1982
... presents reasoning based on the definition of quality given by organized optometry; but no attempt to tie the selection of these variables to consumer preferences is made, nor is there any attempt made to link these measures with outcomes. This somewhat weakens their interpretation as quality...
J Health Polit Policy Law (2001) 26 (2): 464–467.
Published: 01 April 2001
... recently devoted substantial effort to constructing indexes that track the price of medical service bundles such as a hospital stay for a circulatory disorder. These represent a great improvement over previous indexes based on lists of discrete services such as daily...
J Health Polit Policy Law (2011) 36 (4): 775–790.
Published: 01 August 2011
... variation in health care spending between regions of the United States with no difference in outcomes, only 40 percent of which can be attributed to differences in illness and price” (National Busi- ness Group on Health 2009: 6). He credited both Orszag and Dartmouth with the 30 percent savings...
J Health Polit Policy Law (2017) 42 (1): 5–52.
Published: 01 February 2017
... rising prices through direct regulation at the state level. Yet this literature fails to account for how change agents in the states gradually reconfigured the politics of prices, forging new, transparency-based policy instruments called all-payer claims databases (APCDs), which are designed to empower...
J Health Polit Policy Law (2011) 36 (4): 791–801.
Published: 01 August 2011
....2 Earlier research has found that for specific conditions such as heart attacks or hip fractures, differences in health- and price-adjusted spending approach 60 percent between the highest and lowest quintiles of health 2. The quintiles are based on regions where Medicare patients live...
J Health Polit Policy Law (2018) 43 (5): 771–791.
Published: 01 October 2018
.... Lastly, accurate price comparisons depend on adjustments of prices for purchasing power parity (PPP), which convert local prices into an index based on the cost of a basket of goods. On the one hand, this adjustment is well understood and standardized, making it a relatively minor concern. On the other...
J Health Polit Policy Law (1988) 13 (4): 735–752.
Published: 01 August 1988
... NFPs. Moreover, Herzlinger and Krasker ( 1987) claim that rather than using surpluses to enhance quality, NFPs invest them in “flat of the curve” technology (i.e., use of equipment and practices that at best only mar- ginally affect outcomes) to keep physicians happy. Other bases of support...
J Health Polit Policy Law (2020) 45 (5): 787–800.
Published: 01 October 2020
... cultural barriers to the uptake of medical evidence in the US health care system. The growing attention among policymakers and researchers to provider prices (rather than utilization) as the driver of health care spending could be helpful to the political prospects of the evidence-based medicine project by...
J Health Polit Policy Law (1988) 13 (2): 239–261.
Published: 01 April 1988
...Roger Feldman; Frank Sloan Ten years ago we developed a model of demand inducement in the physician services market and explored the properties of that model. We found that predictions concerning physicians' prices, workloads, and income were ambiguous and in many cases were consistent with those...
J Health Polit Policy Law (2009) 34 (6): 1035–1077.
Published: 01 December 2009
...: the use of “performance-based regulation” (May 2003) to reduce these problems. What is here called performance-based regulation is sometimes also called outcome-based regulation. Performance-based regulation seeks to hold enterprises directly responsible for decreasing the harms they know...
J Health Polit Policy Law 8970810.
Published: 22 January 2021
...) the review board would be charged with its own cost-effectiveness analysis to determine a reasonable price for a new treatment relative to the existing standard of care. The recommended prices (i.e., value- based prices ) would then be available to Medicare and other public plans (e.g., the public...